ES2282467T3 - Isoxazolpiridinonas. - Google Patents

Isoxazolpiridinonas. Download PDF

Info

Publication number
ES2282467T3
ES2282467T3 ES02772157T ES02772157T ES2282467T3 ES 2282467 T3 ES2282467 T3 ES 2282467T3 ES 02772157 T ES02772157 T ES 02772157T ES 02772157 T ES02772157 T ES 02772157T ES 2282467 T3 ES2282467 T3 ES 2282467T3
Authority
ES
Spain
Prior art keywords
phenyl
isoxazol
pyridin
methyl
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02772157T
Other languages
English (en)
Spanish (es)
Inventor
Samuel Hintermann
Bastian Hengerer
Ulrike Von Krosigk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Application granted granted Critical
Publication of ES2282467T3 publication Critical patent/ES2282467T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES02772157T 2001-08-15 2002-08-14 Isoxazolpiridinonas. Expired - Lifetime ES2282467T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119911.6A GB0119911D0 (en) 2001-08-15 2001-08-15 Organic Compounds
GB0119911 2001-08-15

Publications (1)

Publication Number Publication Date
ES2282467T3 true ES2282467T3 (es) 2007-10-16

Family

ID=9920454

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02772157T Expired - Lifetime ES2282467T3 (es) 2001-08-15 2002-08-14 Isoxazolpiridinonas.

Country Status (24)

Country Link
US (1) US7087756B2 (enExample)
EP (1) EP1418912B1 (enExample)
JP (1) JP2005501847A (enExample)
KR (1) KR20040029429A (enExample)
CN (1) CN100384418C (enExample)
AR (1) AR036351A1 (enExample)
AT (1) ATE355059T1 (enExample)
BR (1) BR0211903A (enExample)
CA (1) CA2454762A1 (enExample)
CO (1) CO5560566A2 (enExample)
DE (1) DE60218484T2 (enExample)
EC (1) ECSP044971A (enExample)
ES (1) ES2282467T3 (enExample)
GB (1) GB0119911D0 (enExample)
HU (1) HUP0401325A3 (enExample)
IL (1) IL160018A0 (enExample)
MX (1) MXPA04001419A (enExample)
NO (1) NO20040659D0 (enExample)
PE (1) PE20030356A1 (enExample)
PL (1) PL366848A1 (enExample)
PT (1) PT1418912E (enExample)
RU (1) RU2004107847A (enExample)
WO (1) WO2003015780A2 (enExample)
ZA (1) ZA200400525B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102807A1 (en) * 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof
CA2564429A1 (en) * 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
WO2007098047A2 (en) * 2006-02-16 2007-08-30 The Mclean Hospital Corporation Methods and compositions for the treatment of parkinson's disease
EP2051977A2 (en) 2006-07-20 2009-04-29 Amgen Inc. SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr) * 2008-07-10 2010-08-27 Fournier Lab Sa Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
US8173670B2 (en) * 2009-01-13 2012-05-08 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
FR2950053B1 (fr) 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr) 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
DE102011085038A1 (de) 2011-10-21 2013-04-25 Tesa Se Verfahren zur Kapselung einer elektronischen Anordnung
HK1222565A1 (zh) 2013-09-25 2017-07-07 范安德尔研究所 高效糖皮質激素
KR20170033630A (ko) 2015-09-17 2017-03-27 (주)다올 도로용 경계블럭
US10954265B2 (en) 2016-10-14 2021-03-23 Van Andel Research Institute Structures and mechanism for the design of highly potent glucocorticoids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7602542L (sv) 1975-03-14 1976-09-15 Sandoz Ag 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner
US4064251A (en) * 1976-06-25 1977-12-20 Sandoz, Inc. Substituted hydroxy pyridones
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
DE2801190A1 (de) * 1977-01-19 1978-07-20 Sandoz Ag 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat
US4238616A (en) 1977-01-19 1980-12-09 Sandoz, Inc. 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides
US4113727A (en) * 1977-04-26 1978-09-12 Sandoz, Inc. Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones
WO2002102807A1 (en) * 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof

Also Published As

Publication number Publication date
CO5560566A2 (es) 2005-09-30
NO20040659L (no) 2004-02-13
BR0211903A (pt) 2004-09-21
KR20040029429A (ko) 2004-04-06
HUP0401325A2 (hu) 2004-10-28
MXPA04001419A (es) 2004-05-27
CN100384418C (zh) 2008-04-30
ECSP044971A (es) 2004-03-23
US7087756B2 (en) 2006-08-08
DE60218484D1 (de) 2007-04-12
NO20040659D0 (no) 2004-02-13
PT1418912E (pt) 2007-05-31
PL366848A1 (en) 2005-02-07
CN1635889A (zh) 2005-07-06
JP2005501847A (ja) 2005-01-20
WO2003015780A8 (en) 2004-05-21
DE60218484T2 (de) 2007-11-15
EP1418912B1 (en) 2007-02-28
CA2454762A1 (en) 2003-02-27
PE20030356A1 (es) 2003-05-14
ZA200400525B (en) 2005-04-01
US20040248893A1 (en) 2004-12-09
IL160018A0 (en) 2004-06-20
WO2003015780A3 (en) 2003-11-13
RU2004107847A (ru) 2005-05-10
HUP0401325A3 (en) 2005-09-28
ATE355059T1 (de) 2006-03-15
EP1418912A2 (en) 2004-05-19
GB0119911D0 (en) 2001-10-10
WO2003015780A2 (en) 2003-02-27
AR036351A1 (es) 2004-09-01

Similar Documents

Publication Publication Date Title
TWI329111B (en) Azepinoindole and pyridoindole derivatives as pharmaceutical agents
JP6051210B2 (ja) 有機化合物
ES2638912T3 (es) Compuestos orgánicos
JP4679517B2 (ja) 薬剤としてのアゼピン誘導体
EP3116509B1 (en) A new class of mu-opioid receptor agonists
JP2016523974A (ja) Ｉｄｏ阻害剤
JP2016528197A (ja) Ｉｄｏ阻害剤
IL180757A (en) Imidazo[4,5-d] pyrimidines, compositions comprising them and uses thereof for the preparation of medicaments
TW201206944A (en) Morpholine compounds
BR112016025356B1 (pt) Compostos de 4-fenilpiperidinas substituídas, composições e seus usos
TW410224B (en) Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them
WO2023125846A1 (zh) 用于预防和治疗冠状病毒感染的化合物及其偶联物和方法
PT1369419E (pt) Composto de n-fenilarilsulfonamida, fármaco contendo o composto como ingrediente activo, produtos intermédios para a produção do composto e processos para a produção do composto
US7087756B2 (en) Isoxazolopyridinones
JP2023550597A (ja) 甲状腺ホルモン受容体ベータ（ＴＲ－β）アゴニストとしての二環式ピリダジノン
MX2007001539A (es) Compuestos heterociclicos como agentes farmaceuticos.
PT1781296E (pt) Derivados de quinazolina e seu uso no tratamento da trombocitemia
WO2024040245A1 (en) Peptide derivatives and related uses as orexin agonists
CN113979963B (zh) 一种作为甲状腺激素β受体激动剂的化合物及其用途
TW202309038A (zh) sGC刺激劑
WO2025240247A1 (en) Heterocyclic compounds as nrf2 inhibitors
WO2024078618A1 (zh) 一种含氰基取代的多肽类化合物的晶型及其制备方法
WO2024149314A1 (zh) 氨基噻吩类化合物、其制备方法及用途
HK40122606A (en) Indazole pyridone compounds and uses thereof
TW202425969A (zh) 吲唑吡啶酮化合物及其用途